MarpaiRx Appoints Mimi Davis as President to Lead Strategic Growth

Reuters
Jan 28
MarpaiRx Appoints Mimi Davis as President to Lead Strategic Growth

Marpai Inc., a leader in healthcare technology, Pharmacy Benefit Management $(PBM)$, and Third-Party Administration (TPA) services, has announced the hiring of Mimi Davis as President of its subsidiary, MarpaiRx. Davis will oversee the strategic expansion and operational scaling of MarpaiRx's pharmacy benefit offerings. MarpaiRx is focused on delivering innovative, cost-saving pharmacy benefit solutions, leveraging advanced technology and data analytics to enhance the value proposition for members and clients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marpai Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY71884) on January 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10